๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease

โœ Scribed by Kaldor, Stephen W.; Kalish, Vincent J.; Davies, Jay F.; Shetty, Bhasker V.; Fritz, James E.; Appelt, Krzysztof; Burgess, Jeffrey A.; Campanale, Kristina M.; Chirgadze, Nickolay Y.; Clawson, David K.; Dressman, Bruce A.; Hatch, Steven D.; Khalil, Deborah A.; Kosa, Maha B.; Lubbehusen, Penny P.; Muesing, Mark A.; Patick, Amy K.; Reich, Siegfried H.; Su, Kenneth S.; Tatlock, John H.

Book ID
120428697
Publisher
American Chemical Society
Year
1997
Tongue
English
Weight
257 KB
Volume
40
Category
Article
ISSN
0022-2623

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Structure-based discovery of tipranavir
Structure-based discovery of tipranavir disodium (PNU-140690E): A potent, orally bioavailable, nonpeptidic HIV protease inhibitor
โœ Suvit Thaisrivongs; Joseph W. Strohbach ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 167 KB ๐Ÿ‘ 1 views

Efforts to develop therapeutically relevant HIV protease inhibitors as medicinal agents in confronting the AIDS crisis have been aided by the wealth of fundamental information acquired during related drug discovery campaigns against other aspartyl proteases. This knowledge base was brought to full f